SpectraScience: Innovations in Cancer Detection
SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.
Articles by OneMedPlace Team
DesignMedix: Overcoming Drug Resistance
DesignMedix places great emphasis on tackling problems of drug resistant diseases, such as malaria, bacteria, and cancer.
BioLife Solutions: Powering the Preservation Sciences
BioLife Solutions has a strong interest in target markets: regenerative medicine, biobanking, and drug discovery.
Avantis Medical Systems Enters Enormous Endoscope Market
Avantis Medical Systems is company that is tapping into large Endoscope market which has 30 million colonoscopies globally and 15 million in the US alone.
International Stem Cell Corporation Progressing in Human Induced Stem Cells
International Stem Cell Corporation (OTCQB: ISCO) is a biotechnology company that focuses on developing novel stem cell based therapies. Most recently, they have made significant progress in human induced pluripotent stem cells (iPS) and its derivation with novel protein-based reprogramming method.
Plandai Biotechnology Sets for Battle Against Neurological Diseases by using Nutraceuticals
Plandaí Biotechnology, Inc. (OTCQB: PLPL) transforming the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. These extracts are utilized to deliver a new family of drugs to safely and cost effectively treats a plethora of different diseases and conditions.
OneMedRadio: Alliance Health Fund Revolutionizing Communication
A healthcare technology start-up is helping hospitals ensure that clinicians are present at the right time, in the right location, in a more efficient, cost-effective way. IntelliBlast, developed by healthcare technology start-up Targeted Instant Communications (TIC), is the first patented, bi-directional communications software that simplifies staff communications and the shift fulfillment process.
“Corporate Governance Gap” InVivo (NVIV) Delays Listing to National Securities Exchange “Postponed”; Amarantus BioScience (AMBS) DTC Chill Lifted. What is the Next Step for Corporate Governance in the Biotechnology Sector?
Recent challenges to biotechnology companies have been in the form of corporate governance issues, especially those undergoing rapid growth. Two companies in particular, InVivo (NVIV) […]
“SEC’s A Crowd” SEC Finally Issues Determination on Internet-Based Crowdfunding Platforms. How Will This Affect Fundraising?
One of the major obstacles of growth for Internet based Crowdfunding platforms in the U.S. has been the reaction of regulatory authorities. However, two “no-action […]
Editor’s Note, October 24, 2013
Dear Subscriber, In the coming weeks we will be providing short profiles of selected companies presenting at the 7th Annual OneMedForum in San Francisco on […]